Sara Cerenius

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Stenlid, Rasmus; El Amrani, Sami; Cerenius, Sara Y.; Aydin, Banu K. et al.

Part of Cardiovascular Diabetology, 2025

• DOI for Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
• Download full text (pdf) of Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Stenlid, Rasmus; El Amrani, Sami; Cerenius, Sara Y.; Aydin, Banu K. et al.

Part of Cardiovascular Diabetology, 2025

• DOI for Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
• Download full text (pdf) of Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control

Stenlid, Rasmus; Cerenius, Sara Y.; Wen, Quan; Aydin, Banu K. et al.

Part of Frontiers in Endocrinology, 2023

• DOI for Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
• Download full text (pdf) of Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control

Screening for inflammatory markers identifies IL18-Rα as a potential link between exenatide and its anti-inflammatory effect: New results from the Combat-JUDO randomized controlled trial

Stenlid, Rasmus; Cerenius, Sara Y.; Manell, Hannes; Aydin, Banu K. et al.

Part of Annals of Nutrition and Metabolism, p. 522-527, 2023

• DOI for Screening for inflammatory markers identifies IL18-Rα as a potential link between exenatide and its anti-inflammatory effect: New results from the Combat-JUDO randomized controlled trial

Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency

Stenlid, Rasmus; Manell, Hannes; Seth, Rikard; Cerenius, Sara Y. et al.

Part of Metabolites, 2023

• DOI for Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
• Download full text (pdf) of Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Stenlid, Rasmus; El Amrani, Sami; Cerenius, Sara Y.; Aydin, Banu K. et al.

Part of Cardiovascular Diabetology, 2025

• DOI for Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
• Download full text (pdf) of Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Stenlid, Rasmus; El Amrani, Sami; Cerenius, Sara Y.; Aydin, Banu K. et al.

Part of Cardiovascular Diabetology, 2025

• DOI for Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
• Download full text (pdf) of Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS

Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control

Stenlid, Rasmus; Cerenius, Sara Y.; Wen, Quan; Aydin, Banu K. et al.

Part of Frontiers in Endocrinology, 2023

• DOI for Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
• Download full text (pdf) of Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control

Screening for inflammatory markers identifies IL18-Rα as a potential link between exenatide and its anti-inflammatory effect: New results from the Combat-JUDO randomized controlled trial

Stenlid, Rasmus; Cerenius, Sara Y.; Manell, Hannes; Aydin, Banu K. et al.

Part of Annals of Nutrition and Metabolism, p. 522-527, 2023

• DOI for Screening for inflammatory markers identifies IL18-Rα as a potential link between exenatide and its anti-inflammatory effect: New results from the Combat-JUDO randomized controlled trial

Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency

Stenlid, Rasmus; Manell, Hannes; Seth, Rikard; Cerenius, Sara Y. et al.

Part of Metabolites, 2023

• DOI for Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
• Download full text (pdf) of Low Fasting Concentrations of Glucagon in Patients with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency

Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity

Wen, Quan; Stenlid, Rasmus; Chowdhury, Azazul Islam; Ciba, Iris et al.

Part of Metabolites, 2023

• DOI for Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity
• Download full text (pdf) of Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity

High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition

Aydin, Banu K.; Stenlid, Rasmus; Ciba, Iris; Cerenius, Sara Y. et al.

Part of Pediatric Obesity, 2022

• DOI for High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition
• Download full text (pdf) of High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition

Fasting insulin better predicts cardiometabolic risk factors in children and adolescents with obesity than BMI

Stenlid, Rasmus; El Amrani, Sami; Cerenius, Sara Y.; Aydin, Banu K. et al.

The GLP-1 receptor agonist exenatide is associated with improved adherence to health behavior and lifestyle treatment in adolescents with obesity, results from a randomized controlled trial

Stenlid, Rasmus; Cerenius, Sara Y.; Torbahn, Gabriel; Aydin, Banu K. et al.